跳至主要内容
临床试验/NCT06839716
NCT06839716招募中不适用

Prospective Randomized Controlled Study of Ropivacaine-Poloxamer 407 Based Gel Application and TAP Block for Postoperative Pain Management Following Laparoscopic/Robotic Gastrectomy

Gangnam Severance Hospital1 个研究点 分布在 1 个国家目标入组 134 人开始时间: 2025年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
134
试验地点
1
主要终点
Total fentanyl consumption within 72 hours postoperatively.

研究概览

简要总结

This study aims to determine whether Ropivacaine-Poloxamer 407 hydrogel provides non-inferior pain control compared to TAP block for patients undergoing minimally invasive gastrectomy. The results will guide postoperative pain management practices and enhance recovery protocols for gastric cancer surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with a histologically confirmed diagnosis of gastric adenocarcinoma prior to surgery.
  • Patients who have undergone a complete surgical resection (R0 resection).
  • Patients with an ASA (American Society of Anesthesiologists) score of 3 or below.
  • Patients aged 20 years or older.
  • Patients who have undergone laparoscopic or robotic gastrectomy

排除标准

  • Patients under 19 years of age.
  • Presence of ascites or peritoneal metastasis.
  • Patients who have undergone preoperative chemotherapy or radiotherapy.
  • Diagnosis of malignancies other than gastric cancer.
  • Uncontrolled diabetes, autoimmune diseases, hypertrophic scars, or keloid history affecting wound healing.
  • History of allergy or adverse reactions to Ropivacaine or other local anesthetics.
  • Pregnant women.
  • Patients with preoperative chronic pain conditions, including CRPS.
  • Patients with long-term preoperative use of opioid analgesics.
  • Patients with psychiatric disorders deemed likely to interfere with study participation.
  • Patients with severe liver disease, renal disease, or arrhythmia.

结局指标

主要结局

Total fentanyl consumption within 72 hours postoperatively.

时间窗: Over the first 72 hours after surgery.

The total amount of fentanyl administered to the patient via IV PCA during the initial 72-hour postoperative period will be recorded and compared among groups to assess analgesic efficacy.

次要结局

  • Fentanyl usage at 12, 24, 48 hours.(Fentanyl usage at 12, 24, 48 hours.)
  • NRS pain scores at 24, 48, and 72 hours (at rest and during movement).(NRS pain scores(0-10 / 0: no pain / 10: worst pain) at 24, 48, and 72 hours (at rest and during movement).)
  • Pethidine usage at 24, 48, 72 hours(Pethidine usage at 24, 48, 72 hours)
  • Time to first flatus and bowel movement. (up to 1 month)(1 month)
  • Incidence of seroma or surgical site infection. (up to 1 month)(1 month)
  • Quality of Recovery (QoR-15) scores at baseline and 72 hours(72 hours postoperatively)
  • Peak Cough Flow (baseline and 72 hours)(Baseline (preoperatively) and 72 hours postoperatively)
  • Length of hospital stay. (up to 1 month)(up to 1 month)
  • Incidence of postoperative nausea and vomiting (PONV). (up to 72 hours)(72 hours postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

In Gyu Kwon

Assistant Professor

Gangnam Severance Hospital

研究点 (1)

Loading locations...

相似试验